An isotopic rubidium ion efflux assay for the functional characterization of nicotinic acetylcholine receptors on clonal cell lines

Anal Biochem. 1988 Nov 15;175(1):212-8. doi: 10.1016/0003-2697(88)90380-6.


An isotopic rubidium ion efflux assay has been developed for the functional characterization of nicotinic acetylcholine receptors on cultured neurons. This assay first involves the intracellular sequestration of isotopic potassium ion analog by the ouabain-sensitive action of a sodium-potassium ATPase. Subsequently, the release of isotopic rubidium ion through nicotinic acetylcholine receptor-coupled monovalent cation channels is activated by application of nicotinic agonists. Specificity of receptor-mediated efflux is demonstrated by its sensitivity to blockade by nicotinic, but not muscarinic, antagonists. The time course of agonist-mediated efflux, within the temporal limitations of the assay, indicates a slow inactivation of receptor function on prolonged exposure to agonist. Dose-response profiles (i) have characteristic shapes for different nicotinic agonists, (ii) are described by three operationally defined parameters, and (iii) reflect different affinities of agonists for binding sites that control receptor activation and functional inhibition. The rubidium ion efflux assay provides fewer hazards but greater sensitivity and resolution than isotopic sodium or rubidium ion influx assays for functional nicotinic receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Biological Transport, Active / drug effects
  • Carbachol / pharmacology
  • Cell Line
  • Humans
  • Ion Channels / metabolism
  • Kinetics
  • Neurons / drug effects
  • Neurons / metabolism
  • Receptors, Nicotinic / drug effects
  • Receptors, Nicotinic / metabolism*
  • Rubidium Radioisotopes / metabolism*
  • Tubocurarine / pharmacology


  • Ion Channels
  • Receptors, Nicotinic
  • Rubidium Radioisotopes
  • Carbachol
  • Tubocurarine